These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11576445)

  • 1. To find the road traveled to tumor immunity: the trafficking itineraries of molecular chaperones in antigen-presenting cells.
    Berwin B; Nicchitta CV
    Traffic; 2001 Oct; 2(10):690-7. PubMed ID: 11576445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor mediated and fluid phase pathways for internalization of the ER Hsp90 chaperone GRP94 in murine macrophages.
    Wassenberg JJ; Dezfulian C; Nicchitta CV
    J Cell Sci; 1999 Jul; 112 ( Pt 13)():2167-75. PubMed ID: 10362546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of GRP94(Gp96)-associated peptides onto endosomal MHC class I molecules.
    Berwin B; Rosser MF; Brinker KG; Nicchitta CV
    Traffic; 2002 May; 3(5):358-66. PubMed ID: 11967129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/gp96.
    Nicchitta CV
    Curr Opin Immunol; 1998 Feb; 10(1):103-9. PubMed ID: 9523119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunological properties of endoplasmic reticulum chaperones: a conflict of interest?
    Nicchitta CV; Reed RC
    Essays Biochem; 2000; 36():15-25. PubMed ID: 12471899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chaperone-mediated cross-priming: a hitchhiker's guide to vesicle transport (review).
    Reed RC; Nicchitta CV
    Int J Mol Med; 2000 Sep; 6(3):259-64. PubMed ID: 10934286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
    Singh-Jasuja H; Toes RE; Spee P; Münz C; Hilf N; Schoenberger SP; Ricciardi-Castagnoli P; Neefjes J; Rammensee HG; Arnold-Schild D; Schild H
    J Exp Med; 2000 Jun; 191(11):1965-74. PubMed ID: 10839811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides.
    Nair S; Wearsch PA; Mitchell DA; Wassenberg JJ; Gilboa E; Nicchitta CV
    J Immunol; 1999 Jun; 162(11):6426-32. PubMed ID: 10352256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity.
    Nicchitta CV; Carrick DM; Baker-Lepain JC
    Cell Stress Chaperones; 2004; 9(4):325-31. PubMed ID: 15633290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of peptide loading by the tumor rejection antigen/heat shock chaperone gp96 (GRP94).
    Sastry S; Linderoth N
    J Biol Chem; 1999 Apr; 274(17):12023-35. PubMed ID: 10207025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endoplasmic Reticulum Chaperones at the Tumor Cell Surface and in the Extracellular Space].
    Brychtová V; Vojtěšek B
    Klin Onkol; 2016; 29 Suppl 4(Suppl 4):25-30. PubMed ID: 27846717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein-peptide complexes for use in vaccines.
    Heike M; Noll B; Meyer zum Büschenfelde KH
    J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.
    Li Z; Srivastava PK
    EMBO J; 1993 Aug; 12(8):3143-51. PubMed ID: 8344253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic tumor-cell-based vaccines secreting endoplasmic reticulum chaperone gp96.
    Podack ER; Raez LE
    Expert Opin Biol Ther; 2007 Nov; 7(11):1679-88. PubMed ID: 17961091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity.
    Basu S; Srivastava PK
    J Exp Med; 1999 Mar; 189(5):797-802. PubMed ID: 10049943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.
    Leone P; Shin EC; Perosa F; Vacca A; Dammacco F; Racanelli V
    J Natl Cancer Inst; 2013 Aug; 105(16):1172-87. PubMed ID: 23852952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The double role of the endoplasmic reticulum chaperone tapasin in peptide optimization of HLA class I molecules.
    Cabrera CM
    Scand J Immunol; 2007 Jun; 65(6):487-93. PubMed ID: 17523940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen.
    Linderoth NA; Simon MN; Rodionova NA; Cadene M; Laws WR; Chait BT; Sastry S
    Biochemistry; 2001 Feb; 40(5):1483-95. PubMed ID: 11170476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity.
    Graner MW; Romanoski A; Katsanis E
    Int J Hyperthermia; 2013 Aug; 29(5):380-9. PubMed ID: 23725202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells.
    Berwin B; Hart JP; Rice S; Gass C; Pizzo SV; Post SR; Nicchitta CV
    EMBO J; 2003 Nov; 22(22):6127-36. PubMed ID: 14609958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.